Table 2 Comparisons of demographics, baseline neuropsychological test performances, and dementia conversion between the fast- and slow-decliners in patients with naMCI.
From: Prediction Models of Cognitive Trajectories in Patients with Nonamnestic Mild Cognitive Impairment
Fast-decliners (N = 22) | Slow-decliners (N = 99) | P-value | |
---|---|---|---|
Age, years | 74.0 (6.7) | 70.4 (7.3) | 0.037 |
Female, N (%) | 18 (81.8) | 69 (69.7) | 0.253 |
Education, years | 7.7 (5.8) | 9.3 (5.2) | 0.205 |
Total follow-up, years | 3.5 (0.7) | 3.9 (1.4) | 0.049 |
APOE4 carrier, N (%) | 3 (13.6) | 11 (11.1) | 0.634 |
Vascular risk factors | |||
Hypertension, N (%) | 13 (59.1) | 47 (47.5) | 0.324 |
Diabetes, N (%) | 10 (45.5) | 29 (29.3) | 0.142 |
Dyslipidemia, N (%) | 4 (18.2) | 28 (28.3) | 0.331 |
Cardiovascular disease, N (%) | 2 (9.1) | 19 (19.2) | 0.258 |
History of stroke, N (%) | 1 (4.5) | 10 (10.1) | 0.412 |
GDepS | 16.2 (8.1) | 14.8 (8.5) | 0.482 |
CDR-SB | 2.1 (0.8) | 1.1 (0.7) | <0.001 |
Conversion to dementia | 19 (86.4) | 10 (10.1) | <0.001 |
AD | 14 (73.7) | 6 (60.0) | |
DLB | 2 (10.5) | 3 (30.0) | |
SVaD | 2 (10.5) | 1 (10.0) | |
CBS | 1 (5.3) | 0 (0.0) |